1. Home
  2. NBSE

NBSE

NeuBase Therapeutics Inc.

Logo NeuBase Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-17-2024 1:32pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

NeuBase Therapeutics Inc is a pre-clinical stage biopharmaceutical company. It is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides. Its Patrol platform is focused on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy and Familial Parkinson's Disease among others.

Founded: N/A Country:
United States
United States
Employees: N/A City: PITTSBURGH
Market Cap: 1.6M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 235.9K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -7.70 EPS Growth: N/A
52 Week Low/High: $0.39 - $5.40 Next Earning Date: 05-09-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: